AURKA PHARMA
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans to begin clinical development in Q3-2017. Once cleared for clinical development by regulatory authorities, the it compound will be tested directly alone in solid tumors. Later on, the compound may be tested in one of a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.
AURKA PHARMA
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
2016-01-01
Address:
Montrรฉal, Quebec, Canada
Country:
Canada
Website Url:
http://www.aurkapharma.com
Total Employee:
11+
Status:
Active
Similar Organizations
Advanced BioEnergy
Advanced BioEnergy is a liability company formed to develop, construct, own, and operate ethanol plants and other biofuels businesses.
Alera Labs
Alera Labs is a contract research company that provides discovery and development services to medical devices.
Automation & Validation Solutions
Automation & Validation Solutions is committed to going beyond the solution by building strong connections.
Esperas Pharma
Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept.
Current Employees Featured
Investors List
TVM Capital Life Science
TVM Capital Life Science investment in Venture Round - AurKa Pharma
Official Site Inspections
http://www.aurkapharma.com
- Host name: 57.221.168.184.host.secureserver.net
- IP address: 184.168.221.57
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "AurKa Pharma"
AurKa Pharma - Crunchbase Company Profile & Funding
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans โฆSee details»
Aurka Pharma Company Profile 2024: Valuation, Investors
Aurka Pharma General Information Description. Developer of one compound proof-of-concept drug designed to treat tumors. The company's drug are developed mainly to focus on the โฆSee details»
AurKa Pharma - Ownership and Business Overview - Mergr
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018.The largest life science acquisition in 2018 was Shire - which was acquired by Takeda โฆSee details»
AurKa Pharma Inc - Company Profile and News - Bloomberg Markets
Company profile page for AurKa Pharma Inc including stock price, company news, executives, board members, and contact informationSee details»
AurKa Pharma Company Profile | Management and Employees List โฆ
Find contact information for AurKa Pharma. Learn about their Accounting Services, Business Services market share, competitors, and AurKa Pharma's email format.See details»
AurKa Pharma - Overview, News & Similar companies - ZoomInfo
AurKa Pharma's headquarters are located at 1255 Boul. Robert Bourassa Bureau 1610, Montreal, Quebec, H3B 3X3, Canada What is AurKa Pharma's official website?See details»
Lilly to buy cancer drug developer AurKa Pharma
Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora โฆSee details»
AurKa Pharma - Products, Competitors, Financials, Employees ...
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. Use the CB Insights Platform to explore AurKa Pharma's full profile.See details»
AurKa Pharma CEO, Founder, Key Executive Team, Board of โฆ
Explore {AurKa Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Organization | AurKa Pharma Inc. - CDEK
Organization Overview. First Clinical Trial. 2017 NCT03092934. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2017 Timeline < Back; View all... NOW. Now; Active โฆSee details»
Eli Lilly announces its plans to acquire AurKa Pharma
May 17, 2020 Eli Lilly has revealed its agreement to acquire AurKa Pharma, Inc. Established by TVM Capital Life Science, the company has developed oncology compound AK-01, an Aurora โฆSee details»
Lilly to buy Canadaโs AurKa Pharma for $110m
Eli Lilly corporate business development senior vice-president Darren Carroll said: โThe acquisition of AurKa Pharma supports Lillyโs external innovation strategy, in which we seek to โฆSee details»
Lilly to Acquire AurKa Pharma in Deal Worth Up to $575 million
On May 14, 2018, Eli Lilly announced an agreement to acquire AurKa Pharma, a company established by TVM Capital Life Science to develop an oncology compound, in a deal worth up โฆSee details»
Lilly to Acquire AurKa Pharma - American Pharmaceutical Review
May 18, 2018 Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an โฆSee details»
Lilly to acquire AurKa Pharma in $575m deal
May 15, 2018 AurKa Pharma was established as part of the TVM Life Science Ventures VII fund, to develop an Aurora kinase A inhibitor called AK-01. The oncology compound was discovered โฆSee details»
Lilly acquires AurKa | C&EN Global Enterprise - ACS Publications
Eli Lilly & Co. is expanding its cancer drug pipeline by buying back a compound it sold to TVM Capital Life Science in 2016. TVM founded AurKa Pharma to develop the compound, AK-01, โฆSee details»
AURA PHARMACEUTICALS PRIVATE LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AURA PHARMACEUTICALS PRIVATE LIMITED of Mumbai, Maharashtra. Get the latest business โฆSee details»
Aura Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 55 800-444-0000 Aura Pharma is a pharmaceutical company that specializes in the production and distribution of a wide range of โฆSee details»
Aura Pharmaceuticals - Corporate Social Responsibility
As a global organization, we are aware of the fact that people devote a large part of their productive life with us, and also, that we utilise many resources from the society and the โฆSee details»
Auro Pharma Canada
Subsidiary of Aurobindo Pharma Auro Pharma, a Canadian subsidiary of Aurobindo Pharma Ltd.. Aurobindo Pharma is a vertically integrated pharmaceutical organization heavily focused in โฆSee details»